Overview
- The Supreme Court will hear its first abortion case since the reversal of Roe v. Wade, focusing on the FDA's rules for access to the abortion pill mifepristone.
- Fourteen states have total bans and seven others have substantial restrictions on abortion access, affecting the availability of abortion medication.
- The Biden administration defends the FDA's assessment of mifepristone, emphasizing its safety and effectiveness over two decades.
- Abortion pills, particularly mifepristone, have become the most common method of ending pregnancies in the U.S., with a significant increase in use via telehealth.
- Legal and political battles over abortion rights and access to abortion medication continue, with significant implications for reproductive healthcare in the U.S.